Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review

被引:638
|
作者
Hutchinson, John [1 ]
Fogarty, Andrew [1 ]
Hubbard, Richard [1 ]
McKeever, Tricia [1 ]
机构
[1] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England
关键词
INTERSTITIAL LUNG-DISEASES; UNITED-STATES; PREVALENCE; EPIDEMIOLOGY; ALVEOLITIS; SURVIVAL;
D O I
10.1183/09031936.00185114
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
As idiopathic pulmonary fibrosis emerges as an important public health problem, there is a need to coordinate data on incidence and mortality globally. This study aims to systematically assess all available studies to investigate the global burden of disease. Medline and Embase databases were searched systematically for all population-based studies of incidence or mortality of idiopathic pulmonary fibrosis. Clinical case series and prevalence studies were excluded. The search was supplemented using the Google search engine, hand-searching of references and conference abstracts. Data were extracted independently by two authors using a pre-specified proforma, with assessment of methodological quality. 34 studies were identified, providing data from 21 countries from 1968-2012. 28 studies reported incidence data and eight reported mortality data. In studies from the year 2000 onwards, we estimated a conservative incidence range of 3-9 cases per 100000 per year for Europe and North America. Incidence was lower in East Asia and South America. The majority of studies showed an increase in incidence over time. The incidence of idiopathic pulmonary fibrosis is increasing worldwide and rates are coming together across countries. Current data suggest incidence is similar to that of conditions such as stomach, liver, testicular and cervical cancers.
引用
收藏
页码:795 / 806
页数:12
相关论文
共 50 条
  • [31] The effect of CALIPER-derived parameters for idiopathic pulmonary fibrosis in predicting prognosis, progression, and mortality: a systematic review
    Xin-yao Jiao
    Han Song
    Wei-wu Liu
    Jun-ling Yang
    Zhi-wei Wang
    Dan Yang
    Sa Huang
    European Radiology, 2023, 33 : 7262 - 7273
  • [32] The effect of CALIPER-derived parameters for idiopathic pulmonary fibrosis in predicting prognosis, progression, and mortality: a systematic review
    Jiao, Xin-yao
    Song, Han
    Liu, Wei-wu
    Yang, Jun-ling
    Wang, Zhi-wei
    Yang, Dan
    Huang, Sa
    EUROPEAN RADIOLOGY, 2023, 33 (10) : 7262 - 7273
  • [33] Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
    Jaana Kaunisto
    Eija-Riitta Salomaa
    Ulla Hodgson
    Riitta Kaarteenaho
    Marjukka Myllärniemi
    BMC Pulmonary Medicine, 13
  • [34] Environmental and occupational exposures and the risk of idiopathic pulmonary fibrosis: A systematic review
    Manna, Eliza Del Fiol
    Pocetta, Giancarlo
    Folletti, Ilenia
    Paolocci, Giulia
    Rodrigues, Cibele
    GIORNALE ITALIANO DI MEDICINA DEL LAVORO ED ERGONOMIA, 2021, 43 (01) : 21 - 27
  • [35] Care programs and their components for patients with idiopathic pulmonary fibrosis: a systematic review
    Anouk Delameillieure
    Sarah Vandekerkhof
    Bastiaan Van Grootven
    Wim A. Wuyts
    Fabienne Dobbels
    Respiratory Research, 22
  • [36] Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis: An Overview of Systematic Review
    Li, Ming
    Wu, Ruohan
    Li, Meng
    Zhao, Yuanchen
    Li, Lei
    Li, Guangxi
    Liu, Shigang
    Li, Hui
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (06) : 150 - 157
  • [37] Impact of antifibrotic therapy on lung cancer incidence and mortality in patients with idiopathic pulmonary fibrosis
    Jo, Yong Suk
    Kim, Kyung Joo
    Rhee, Chin Kook
    Kim, Yong Hyun
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [38] Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
    Kaunisto, Jaana
    Salomaa, Eija-Riitta
    Hodgson, Ulla
    Kaarteenaho, Riitta
    Myllarniemi, Marjukka
    BMC PULMONARY MEDICINE, 2013, 13
  • [39] Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review
    Kamiya, Hiroyuki
    Panlaqui, Ogee Mer
    BMJ OPEN, 2018, 8 (03):
  • [40] Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    Aravena, Carlos
    Labarca, Gonzalo
    Venegas, Carmen
    Arenas, Alex
    Rada, Gabriel
    PLOS ONE, 2015, 10 (08):